About BaroFold
BaroFold is a company based in Aurora (United States) founded in 2003 by Matthew Seefeldt and Matt Brewer was acquired by Pressure BioSciences in December 2017. BaroFold has raised $16.35 million across 4 funding rounds from investors including HBM Healthcare Investments, Pressure BioSciences and Boulder Ventures. BaroFold offers products and services including Barocycler 2320EXT and BaroShear TM K45. BaroFold operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
- Headquarter Aurora, United States
- Founders Matthew Seefeldt, Matt Brewer
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pressure Biosciences, Inc.
-
Annual Revenue
$1.98 M (USD)14as on Dec 31, 2023
-
Net Profit
-$29.31 M (USD)-82as on Dec 31, 2023
-
EBITDA
-$9.5 M (USD)-94as on Dec 31, 2023
-
Total Equity Funding
$16.35 M (USD)
in 4 rounds
-
Latest Funding Round
$1.7 M (USD), Series A
Feb 20, 2013
-
Investors
HBM Healthcare Investments
& 2 more
-
Employee Count
Not available
-
Acquired by
Pressure BioSciences
(Dec 13, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BaroFold
BaroFold offers a comprehensive portfolio of products and services, including Barocycler 2320EXT and BaroShear TM K45.
Compact instrument for processing biological samples using high pressure.
System for preparing high-quality nanoemulsions of substances like CBD oil.
People of BaroFold
Unlock access to complete
Funding Insights of BaroFold
BaroFold has successfully raised a total of $16.35M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.7 million completed in February 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BaroFold
BaroFold has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include HBM Healthcare Investments, Pressure BioSciences and Boulder Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Locked | Locked | Locked | |
|
Life sciences focused VC firm funding companies in the US and Europe
|
Locked | Locked | Locked | |
|
Biomolecular reactions are controlled via pressure cycling technology.
|
Locked | Locked | Locked |
Investor details for BaroFold
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BaroFold
Investment portfolio details for BaroFold
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BaroFold
Detailed financials for BaroFold
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Barofold Comparisons
Peer comparison for BaroFold
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BaroFold
BaroFold operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
Detailed competitors of BaroFold
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Barofold
Complete news archive for BaroFold
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BaroFold
BaroFold was founded in 2003 and raised its 1st funding round 4 years after it was founded.
BaroFold is headquartered in Aurora, United States. It is registered at Aurora, Colorado, United States.
Matt Brewer is the current CEO of BaroFold. They have also founded this company.
BaroFold is a funded company, having raised a total of $16.35M across 4 funding rounds to date.
Annual revenue of BaroFold is $1.98M as on Dec 31, 2023.
BaroFold was established in 2003 in Aurora, United States, as a biopharmaceutical entity focused on immunology. Protein therapeutics are developed and commercialized using proprietary PreEMT high-pressure folding technology alongside other advanced methods. The pipeline targets conditions such as Multiple Sclerosis, Rheumatoid Arthritis, and Asthma, with operations centered on therapeutic innovation in the immunology sector.
BaroFold's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
BaroFold offers Barocycler 2320EXT and BaroShear TM K45.
BaroFold has 3 investors. Key investors include HBM Healthcare Investments, Pressure BioSciences, and Boulder Ventures.